Louise R. Rodino-Klapac, Ph.D.
Affiliations: | 2005 | Ohio State University, Columbus, Columbus, OH |
Area:
Motor Axon GuidanceGoogle:
"Louise Rodino-Klapac"Mean distance: 17.91 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentorChristine Beattie | grad student | 2005 | Ohio State | |
(Genetic analysis of motor axon pathfinding in zebrafish.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Mendell JR, Pozsgai ER, Lewis S, et al. (2024) Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E/R4: phase 1/2 trial results. Nature Medicine |
Potter RA, Griffin DA, Heller KN, et al. (2023) Expression and function of Four AAV-based constructs for dystrophin restoration in the mdx mouse model of duchenne muscular dystrophy. Biology Open |
Seo YE, Baine SH, Kempton AN, et al. (2023) Systemic γ-sarcoglycan AAV gene transfer results in dose-dependent correction of muscle deficits in the LGMD 2C/R5 mouse model. Molecular Therapy. Methods & Clinical Development. 28: 284-299 |
Crowe KE, Zygmunt DA, Heller K, et al. (2021) Visualizing Muscle Sialic Acid Expression in the GNED207VTgGne-/- Cmah-/- Model of GNE Myopathy: A Comparison of Dietary and Gene Therapy Approaches. Journal of Neuromuscular Diseases |
Potter RA, Griffin DA, Heller KN, et al. (2021) Dose-Escalation Study of Systemically Delivered rAAVrh74.MHCK7.micro-dystrophin in the Mouse Model of Duchenne Muscular Dystrophy. Human Gene Therapy |
Griffin DA, Pozsgai ER, Heller KN, et al. (2020) Pre-clinical Systemic Delivery of Adeno-Associated Alpha-Sarcoglycan Gene Transfer for Limb-Girdle Muscular Dystrophy. Human Gene Therapy |
Mendell JR, Sahenk Z, Lehman K, et al. (2020) Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial. Jama Neurology |
Asher DR, Thapa K, Dharia SD, et al. (2020) Clinical Development on the Frontier: Gene Therapy for Duchenne Muscular Dystrophy. Expert Opinion On Biological Therapy |
Alfano LN, Charleston JS, Connolly AM, et al. (2019) Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy. Medicine. 98: e15858 |
Mendell JR, Chicoine LG, Al-Zaidy SA, et al. (2019) Gene Delivery for Limb-Girdle Muscular Dystrophy Type 2D (LGMD2D). Human Gene Therapy |